Australian equities: what moved the ASX 200? Australian shares finished lower on Friday, 6 November, as the technology-led sell-off on Wall Street spread across global markets. T...
Mark Elzayed•
Danny Aad
Alison Elzayed
Alison Elzayed
Alison Elzayed
At Albion Resources, we are making encouraging progress at our Gidgee gold project in Western Australia. Our latest dril...
Peter Goh
At The Calmer Co International ASX: CCO, we are focused on turning growing consumer demand for kava products into a larg...
Zane Yoshida
Mayne Pharma Group Limited ASX: MYX is taking a decisive step towards becoming a US-focused pharmaceutical company, agreeing to sell its international operations for $55.5 million. The tran...
Danny Aad•
Qantas Airways Limited ASX: QAN faces a $3.75 billion first-half fuel bill after increasing its previous forecast by $150 million, placing renewed pressure on profitability despite resilient...
Mark Elzayed•
AVITA Medical Inc. ASX: AVH has delivered 53% quarterly revenue growth, improved margins and sharply reduced cash consumption, strengthening its prospects of reaching cash flow breakeven bef...
Danny Aad•
Macquarie Group Limited ASX: MQG has delivered a 50% increase in first-half profit to $2.48 billion, exceeding market expectations as commodities trading strengthened earnings. However, a ne...
Mark Elzayed•Australian equities: what moved the ASX 200? Australian shares finished lower on Friday, 6 November, as the technology-led sell-off on Wall Street spread across global markets. The ASX 200...
Mark Elzayed•Epiminder Limited ASX: EPI has expanded the US market for its epilepsy monitoring technology following a significant regulatory clearance, strengthening its commercial prospects ahead of a p...
Danny Aad•A 38-metre gold intersection grading 2.1 grams per tonne has given Asara Resources Limited ASX: AS1 an encouraging exploration result beyond its established Massan deposit in Guinea. The dis...
Alison Elzayed•Alvo Minerals Limited ASX: ALV has extended rare earth mineralisation approximately 2 kilometres beyond previously tested areas at its Boa Vista prospect in Brazil, strengthening the explora...
Alison Elzayed•Avenira Limited ASX: AEV has reached a significant financing milestone, with its $48.9 million rights issue providing fresh capital to advance the Wonarah Phosphate Project in the Northern T...
Alison Elzayed•Mayne Pharma Group Limited ASX: MYX is taking a decisive step towards becoming a US-focused pharmaceutical company, agreeing to sell its international operations for $55.5 million. The tran...
Danny Aad•